Table 2.
Quintiles (Q) of meat group intakeb
|
p-trend | p-heteroc | |||||
---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q5 | |||
Total meat | |||||||
Median (g/1,000kcal) | 28.1 | 46.3 | 61.1 | 77.7 | 106.9 | ||
Total No. of cases | 1,740 | 1,874 | 1,880 | 1,943 | 1,859 | ||
All breast cancer | 1.00 | 1.05 (0.98 – 1.12) | 1.06 (0.99 – 1.13) | 1.09 (1.02 – 1.17) | 1.06 (0.99 – 1.13) | 0.10 | |
In-situ | 1.00 | 1.05 (0.90 – 1.22) | 1.15 (0.99 – 1.34) | 1.20 (1.03 – 1.40) | 1.06 (0.90 – 1.24) | 0.30 | |
Localized | 1.00 | 1.08 (0.97 – 1.20) | 1.14 (1.03 – 1.27) | 1.07 (0.96 – 1.19) | 1.09 (0.97 – 1.22) | 0.30 | |
Regional/distant | 1.00 | 1.07 (0.90 – 1.28) | 1.12 (0.94 – 1.33) | 1.09 (0.92 – 1.30) | 1.15 (0.96 – 1.37) | 0.16 | 0.74 |
ER+/PR+ | 1.00 | 1.05 (0.94 – 1.18) | 1.06 (0.94 – 1.19) | 1.14 (1.02 – 1.28) | 1.00 (0.99 – 1.13) | 0.83 | |
ER−/PR− | 1.00 | 0.86 (0.68 – 1.09) | 0.99 (0.79 – 1.25) | 0.94 (0.74 – 1.19) | 0.87 (0.68 – 1.11) | 0.42 | 0.35 |
Total processed meat | |||||||
Median (g/1,000kcal) | 1.1 | 3.3 | 5.7 | 9.4 | 18.4 | ||
Total No. of cases | 1,819 | 1,838 | 1,822 | 1,943 | 1,883 | ||
All breast cancer | 1.00 | 0.99 (0.93 – 1.06) | 0.98 (0.92 – 1.05) | 1.05 (0.98 – 1.13) | 1.04 (0.97 – 1.12) | 0.09 | |
In-situ | 1.00 | 0.97 (0.83 – 1.13) | 1.21 (1.04 – 1.42) | 1.03 (0.88 – 1.21) | 1.08 (0.92 – 1.27) | 0.46 | |
Localized | 1.00 | 1.07 (0.96 – 1.19) | 1.05 (0.94 – 1.17) | 1.14 (1.02 – 1.28) | 1.14 (1.01 – 1.27) | 0.03 | |
Regional/distant | 1.00 | 0.98 (0.82 – 1.17) | 0.98 (0.82 – 1.18) | 1.15 (0.97 – 1.38) | 1.10 (0.92 – 1.32) | 0.10 | 0.74 |
ER+/PR+ | 1.00 | 0.94 (0.84 – 1.05) | 0.90 (0.80 – 1.01) | 0.98 (0.87 – 1.10) | 0.96 (0.85 – 1.09) | 0.94 | |
ER−/PR− | 1.00 | 1.01 (0.80 – 1.28) | 0.89 (0.70 – 1.14) | 0.84 (0.66 – 1.08) | 1.01 (0.79 – 1.29) | 0.91 | 0.99 |
Total red meat | |||||||
Median (g/1,000kcal) | 7.8 | 17.6 | 26.4 | 36.6 | 54.7 | ||
Total No. of cases | 1,758 | 1,865 | 1,926 | 1,939 | 1,817 | ||
All breast cancer | 1.00 | 1.04 (0.97 – 1.11) | 1.06 (0.99 – 1.14) | 1.10 (1.02 – 1.18) | 1.04 (0.97 – 1.13) | 0.27 | |
In-situ | 1.00 | 1.10 (0.94 – 1.28) | 1.07 (0.91 – 1.26) | 1.21 (1.02 – 1.42) | 1.04 (0.87 – 1.24) | 0.63 | |
Localized | 1.00 | 1.06 (0.96 – 1.19) | 1.13 (1.01 – 1.26) | 1.17 (1.04 – 1.31) | 1.04 (0.92 – 1.18) | 0.53 | |
Regional/distant | 1.00 | 1.08 (0.90 – 1.30) | 1.21 (1.01 – 1.46) | 1.26 (1.05 – 1.52) | 1.25 (1.03 – 1.52) | 0.02 | 0.20 |
ER+/PR+ | 1.00 | 1.04 (0.93 – 1.17) | 1.10 (0.98 – 1.24) | 1.09 (0.97 – 1.23) | 0.97 (0.85 – 1.11) | 0.59 | |
ER−/PR− | 1.00 | 1.07 (0.85 – 1.35) | 0.85 (0.66 – 1.09) | 0.89 (0.69 – 1.15) | 0.95 (0.73 – 1.24) | 0.47 | 0.42 |
Fresh red meat (unprocessed) | |||||||
Median (g/1,000kcal) | 5.5 | 13.0 | 19.7 | 28.0 | 43.4 | ||
Total No. of cases | 1,795 | 1,820 | 1,922 | 1,859 | 1,910 | ||
All breast cancer | 1.00 | 1.00 (0.93 – 1.07) | 1.02 (0.95 – 1.09) | 1.07 (1.00 – 1.15) | 1.03 (0.96 – 1.11) | 0.19 | |
In-situ | 1.00 | 0.99 (0.85 – 1.15) | 1.02 (0.87 – 1.19) | 1.08 (0.92 – 1.26) | 1.01 (0.85 – 1.20) | 0.67 | |
Localized | 1.00 | 1.07 (0.96 – 1.19) | 1.04 (0.93 – 1.17) | 1.12 (1.00 – 1.25) | 1.01 (0.89 – 1.14) | 0.99 | |
Regional/distant | 1.00 | 0.99 (0.82 – 1.18) | 1.15 (0.96 – 1.37) | 1.23 (1.03 – 1.48) | 1.16 (0.96 – 1.41) | 0.02 | 0.48 |
ER+/ER+ | 1.00 | 1.05 (0.94 – 1.18) | 1.06 (0.94 – 1.20) | 1.13 (1.00 – 1.27) | 1.04 (0.92 – 1.19) | 0.50 | |
ER−/PR− | 1.00 | 1.04 (0.82 – 1.31) | 0.90 (0.70 – 1.14) | 0.82 (0.63 – 1.06) | 1.03 (0.80 – 1.34) | 0.93 | 0.19 |
Processed red meat | |||||||
Median (g/1,000kcal) | 1.1 | 2.8 | 4.8 | 7.6 | 14.5 | ||
Total No. of cases | 1,759 | 1,922 | 1,807 | 1,929 | 1,888 | ||
All breast cancer | 1.00 | 1.07 (1.00 – 1.14) | 1.01 (0.94 – 1.09) | 1.10 (1.02 – 1.18) | 1.09 (1.01 – 1.17) | 0.05 | |
In-situ | 1.00 | 0.98 (0.84 – 1.15) | 1.13 (0.97 – 1.33) | 1.14 (0.97 – 1.34) | 1.07 (0.90 – 1.28) | 0.41 | |
Localized | 1.00 | 1.11 (0.99 – 1.24) | 1.09 (0.97 – 1.22) | 1.25 (1.11 – 1.40) | 1.27 (1.13 – 1.44) | <0.0001 | |
Regional/distant | 1.00 | 1.10 (0.92 – 1.31) | 1.07 (0.89 – 1.29) | 1.14 (0.95 – 1.38) | 1.19 (0.98 – 1.44) | 0.10 | 0.28 |
ER+/ER+ | 1.00 | 1.06 (0.94 – 1.18) | 0.97 (0.86 – 1.10) | 1.03 (0.91 – 1.17) | 0.99 (0.87 – 1.13) | 0.67 | |
ER−/PR− | 1.00 | 1.15 (0.92 – 1.44) | 0.84 (0.66 – 1.08) | 0.83 (0.64 – 1.08) | 0.83 (0.64 – 1.09) | 0.05 | 0.28 |
Total white meat | |||||||
Median (g/1,000kcal) | 9.9 | 19.5 | 29.2 | 42.2 | 69.1 | ||
Total No. of cases | 1,794 | 1,820 | 1,922 | 1,859 | 1,910 | ||
All breast cancer | 1.00 | 0.98 (0.92 – 1.05) | 1.04 (0.98 – 1.11) | 1.00 (0.93 – 1.06) | 1.03 (0.97 – 1.11) | 0.27 | |
In-situ | 1.00 | 1.03 (0.88 – 1.20) | 1.16 (1.00 – 1.35) | 1.07 (0.92 – 1.25) | 1.11 (0.96 – 1.30) | 0.21 | |
Localized | 1.00 | 1.06 (0.95 – 1.18) | 1.09 (0.98 – 1.21) | 1.02 (0.92 – 1.14) | 1.07 (0.96 – 1.19) | 0.45 | |
Regional/distant | 1.00 | 0.94 (0.80 – 1.12) | 0.92 (0.78 – 1.09) | 1.01 (0.85 – 1.19) | 1.02 (0.86 – 1.20) | 0.49 | 0.88 |
ER+/PR+ | 1.00 | 1.01 (0.90 – 1.13) | 1.03 (0.92 – 1.15) | 0.99 (0.88 – 1.11) | 1.02 (0.91 – 1.15) | 0.79 | |
ER−/PR− | 1.00 | 0.83 (0.65 – 1.06) | 0.95 (0.75 – 1.20) | 1.05 (0.83 – 1.31) | 0.90 (0.71 – 1.14) | 0.93 | 0.61 |
Adjusted for age (continuous), race (White, Black, other), BMI (continuous), height (continuous), education level (< high school, high school, > high school), cigarette smoking (never, quit ≥ 5 y ago, quit 1–4 y ago, quit < 1 y ago, current smoking), alcohol intake (continuous), physical activity (low, moderate, high), familial history of breast cancer (yes/no), age at menarche (< 13, 13–14, ≥15), age at menopause (< 45, 45–49, 50–54, ≥55), age at first live birth (nulliparous, < 25, 25–29, ≥30), number of live births (nulliparous, 1–2, ≥3), hormone use (never, former, current), oral contraceptive use (never, ever), numbers of previous breast biopsy (0, 1, 2, ≥3), total calorie intake (continuous), total fat intake (continuous), fiber intake (continuous), and intake of other types of meat (white, red, processed, processed red, processed white, unprocessed, unprocessed red, unprocessed white meats, if applicable).
Intake density (g/1,000 kcal)
p values for heterogeneity of the associations among cancer stages (in situ, localized, and regional/distant) and among ER/PR status (ER+/PR+, ER+/PR−, ER−/PR+, and ER−/PR−) using medians of quintile intakes as continuous variables.